CLINICAL_TRIALS
research
· 2014-02-26
Clinical Trial Update: Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer [Phase 2]
Summary
A Phase 2 trial compares paclitaxel plus raltitrexed against Taxol (paclitaxel) as second-line therapy for advanced gastric cancer; the current status is unknow…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fudan University | Conditions: Advanced Gastric Cancer | Phase 2 | Status: UNKNOWN